SlideShare a Scribd company logo
1 of 29
Post transplantation strictures: which
  stent type and optimal staging?
              Mario Traina


                                     1
Post transplantation strictures
           Background
Biliary complications represent a serious source of
morbidity after OLT (Orthotopic Liver Transplantation) and
LRLT (Living Related Liver Transplantation)

The rate of biliary complications in transplant recipients
ranging from 8% to 35% in the published series

The most common biliary complication is the
anastomotic stricture, which is followed by biliary
leakage, although patients often develop more than one
complication
                                                         2
Post transplantation strictures
    Predictors of biliary complications by multivariate
                          analysis
• Take-back surgery after liver transplantation was identified
as strongly predictive of the development of a biliary
problem.

• Patients who received a DCD (Donation after Cardiac Death) graft
had a 4.5-fold increased risk of the development of a biliary
complication.

• Patients with PSC (primary sclerosing clolangitis) had a 2.8-fold
increase in the risk of the development of biliary problems.


                                                                  3
Post transplantation strictures
           Standard Treatment
  The standard endoscopic treatment consists in performing
  ERCP, with sphincterotomy plus stent placement for
  biliary leaks, or progressive pneumatic dilatation with
  stents placement for biliary stenosis alone

Results :
 The endoscopic treatment of biliary complications reaches
  a success rate of about 70-80% after orthotopic liver
  transplantation and 60% after living-related liver
  transplantation.


                                                             4
Post transplantation strictures
  Predictors of endoscopic treatment outcomes
•Patients who had grafts from DCD and in whom biliary
complications developed were less likely to respond to
endoscopic therapy.

•Patients who received a living donor liver transplant were
less likely to respond to endoscopic therapy.

•Finally, transplant recipients who had undergone take-back
surgery for nonbiliary indications, particularly bleeding, had
less favorable endoscopic results for the management of
biliary problems.


                                                             5
Multivariate analysis
demostrated that
treatment success was
directly related to the
number of stent used




                          6
Post transplantation strictures
           Which stent type
The    rationale  for   using
covered metallic stent was to
improve the durability of
patency, because the plastic
stents have limited patency
rate and become occluded
within 3 to 6 months, so that
frequent replacement and an
increasing number of stents
are required.

                                      7
Post transplantation strictures
    SEMS (self-expanding metal stents)

• Uncovered
• Partially covered
• Fully covered: Silicon, Permalume®, PTFE
  (Polytetrafluoroethylene), Gore-tex,
• Steel, Nitinol, Platinol™
• Conforming to anatomy
Antimigration properties
•   Flared type
•   Anchoring fins
•   Anchoring flaps
•   Bumpy
                                             8
Post transplantation strictures
         Covered SEMS




                                  9
Post transplantation strictures
                  Treatment with SEMS
•Traina M, Tarantino I, Barresi L, et al. Efficacy and safety of fully covered
selfexpandable metallic stents in biliary complications after liver
transplantation: a preliminary study. Liver Transpl 2009; 15:1493–1498.

•Tee HP, James MW, Kaffes AJ. Placement of removable metal biliary stent
in postorthotopic liver transplantation anastomotic stricture. World J
Gastroenterol 2010; 16:3597–3600.

•Garcıa-Pajares F, Sanchez-Antolın G, Pelayo SL, et al. Covered metal
stents for the treatment of biliary complications after orthotopic liver
transplantation. Transplant Proc 2010; 42:2966–2969.

•Chaput U, Scatton O, Bichard P, et al. Temporary placement of partially
covered self-expandable metal stents for anastomotic biliary strictures after
liver transplantation: a prospective, multicenter study. Gastrointest Endosc
2010; 72:1167–1174.

                                                                                 10
Post transplantation strictures




                                  11
Post transplantation strictures




                                  12
Post transplantation strictures




                                  13
Post transplantation strictures




                                  14
Post transplantation strictures




                                  15
Post transplantation strictures

Now that fully CSEMS are available, partially
CSEMS should not be used due to imbedding
of the uncovered portion, which has the
potential for causing stent-induced strictures
and to make stent removal difficult or
impossible.
                              Todd H. Baron




                                              16
Post transplantation strictures

 • Our preliminary data showed that in patients who do not respond to
   standard endoscopic treatment, the placement of a fully covered
   metal stent could be considered a valid alternative to surgery.
 • These results were limited in generalizability by a short follow-up
   time (a mean of 10 months) and a small patient’s cohort.


With the present study we aim to implement our previous
experience with longer follow-up period and higher
number of treated patients, analyzing the efficacy of
SEMS both as first-line approach and in patients in whom
plastic stents failed in resolving the biliary complication


                                                                     17
Post transplantation strictures
                       AIMS of the study

     To evaluate the clinical success in a large cohort of
     patients treated with SEMS, after failure of
     conventional endoscopic treatment*, and with a long
     follow up.
     To evaluate the clinical success of SEMS placement
     as first procedure in a subgroup of consecutive
     treated patients.

*Failure of endoscopic treatment was defined as: 1) evidence of continuous
bile leakage despite endoscopic stent placement; 2) persistence of stenosis
after one year despite multiple dilatation and stent placement

                                                                              18
Post transplantation strictures
         Study design
     • Prospective observational study

              Population of patients with
                 biliary complications
              after liver transplantation
                    (OLT and LRLT)




   After failure of
     conventional                 First diagnosis
 endoscopic treatment


                                                    19
Post transplantation strictures
     Materials and Methods

  From January 2008 to August 2010, all failures of
endoscopic conventional therapy, were treated with
SEMS placement according with our previous series.



   From January to August 2010, we also tried to treat all
new cases without any previous endoscopic
treatments, with SEMS placement as first approach.



                                                         20
Post transplantation strictures
           Results
                         54
                  consecutive patients
               were treated with SEMS
              for biliary stenosis and/or
            leak after liver transplantation
            and were included in the study




       39
  after failure of                       15
    conventional                   as first approach
     treatment

                                                       21
Post transplantation strictures
         Patients Characteristic
                        GROUP 1 (39)   GROUP 2 (15)
 MALE/FEMALE N              25/14          10/5
   MEAN AGE               60.1 ± 8.9     59.1 ± 6.6
  LIVER DONORS
     •Cadaveric          33 (84.6%)      15 (100%)
       • Living           6 (15.4%)           -
     BILIARY
  ANASTOMOSIS
   •Duct-to-duct          35 (89.7)      15 (100)
•Multiple anastomosis      4 (10.3)          -

 COMPLICATIONS
     • Stenosis            32 (82)       15 (100)
• Stenosis plus leak       6 (15.4)          -
       • Leak              1 (2.6)           -        22
Post transplantation strictures
                Results
                       GROUP 1 (39)        GROUP 2 (15)


   SOLUTION N (%)        28/39 (71.8)        8/15 (53.3)

  MEAN FOLLOW-UP        16.6±9 months      10.4±4.5 months

 RECURRENCE n (%)         4/28 (14.3)          2/8 (25)


TIME OF RECURRENCE     8.5 months (3-24)   1 and 13 months


SEMS MIGRATION n (%)     13/39 (33.3)        7/15 (46.7)


                                                             23
Post transplantation strictures
                 Anchoring Fins




Removal may be problematic because of
these multiple anchoring fins, which can
cause ulceration and bleeding from the
mucosa as the SEMS is extracted.

                                           24
Post transplantation strictures
Anchoring Flap e Flared end




                                  25
Post transplantation strictures
               Bumpy
•




                                      26
Post transplantation strictures
            Bumpy




                                  27
Post transplantation strictures
           Bumpy




                                  28
Post transplantation strictures
           Conclusions
• ERCP with conventional treatment is a safe first-line
  approach for post-OLT biliary complications.
• In patients in whom the standard approach fails
  temporary SEMS placement is able to solve biliary
  complication and may eliminate the need for surgery in
  almost ¾ of cases.
• SEMS placement is not useful and not recommended as
  first line approach soon after the diagnosis of biliary
  complications
• Partially CSEMS should not be used due to imbedding of
  the uncovered portion
• The ideal stent: fully covered, flared, conforming to
  anatomy, with a safe antimigration system

                                                       29

More Related Content

What's hot

In most cases evar substituted conventional repaire for ruptured aaa why
In most cases evar substituted conventional repaire for  ruptured aaa whyIn most cases evar substituted conventional repaire for  ruptured aaa why
In most cases evar substituted conventional repaire for ruptured aaa whyuvcd
 
COMPOSITE GRAFT: ANTROPYLORUS TRANSPOSITION AND GLUTEUS MAXIMUS WRAP
COMPOSITE GRAFT: ANTROPYLORUS TRANSPOSITION AND GLUTEUS MAXIMUS WRAPCOMPOSITE GRAFT: ANTROPYLORUS TRANSPOSITION AND GLUTEUS MAXIMUS WRAP
COMPOSITE GRAFT: ANTROPYLORUS TRANSPOSITION AND GLUTEUS MAXIMUS WRAPDr Amit Dangi
 
Dr Pradeep Jain Fortis Hospital - Current Applications of Lap in GI Surgery
Dr Pradeep Jain Fortis Hospital - Current Applications of Lap in GI SurgeryDr Pradeep Jain Fortis Hospital - Current Applications of Lap in GI Surgery
Dr Pradeep Jain Fortis Hospital - Current Applications of Lap in GI SurgeryDr Pradeep Jain Reviews
 
Allograft replacement for infrarenal aortic graft infection
Allograft  replacement  for infrarenal  aortic graft infectionAllograft  replacement  for infrarenal  aortic graft infection
Allograft replacement for infrarenal aortic graft infectionuvcd
 
New technology new technique radiofrequency results 5 years
New technology new technique  radiofrequency results 5 yearsNew technology new technique  radiofrequency results 5 years
New technology new technique radiofrequency results 5 yearsuvcd
 
Resection of vena cava during major hepatectomies
Resection of vena cava during major hepatectomiesResection of vena cava during major hepatectomies
Resection of vena cava during major hepatectomiesMarcel Autran Machado
 
Art 3 a10.1007-2fs00464-011-2009-2
Art 3 a10.1007-2fs00464-011-2009-2Art 3 a10.1007-2fs00464-011-2009-2
Art 3 a10.1007-2fs00464-011-2009-2Sameh Naguib
 
Robotic pancreatectomy. Pancreatectomia robótica.
Robotic pancreatectomy. Pancreatectomia robótica.Robotic pancreatectomy. Pancreatectomia robótica.
Robotic pancreatectomy. Pancreatectomia robótica.Marcel Autran Machado
 
Glissonian approach for laparoscopic liver resections
Glissonian approach for laparoscopic liver resectionsGlissonian approach for laparoscopic liver resections
Glissonian approach for laparoscopic liver resectionsMarcel Autran Machado
 
Laparoscopic Ivor Lewis Esophagectomy
Laparoscopic Ivor Lewis EsophagectomyLaparoscopic Ivor Lewis Esophagectomy
Laparoscopic Ivor Lewis EsophagectomyPradeep Jain
 
Hybrid tevar for the treatment of aortic dissection
Hybrid tevar for the treatment of aortic dissectionHybrid tevar for the treatment of aortic dissection
Hybrid tevar for the treatment of aortic dissectionuvcd
 
Advanced and laparoscopic liver, bile duct and pancreatic surgery
Advanced and laparoscopic liver, bile duct and pancreatic surgeryAdvanced and laparoscopic liver, bile duct and pancreatic surgery
Advanced and laparoscopic liver, bile duct and pancreatic surgeryhr77
 
Massive bone allografts
Massive bone allograftsMassive bone allografts
Massive bone allograftsRaunak Milton
 
COMPARATIVE STUDY BETWEEN LAPAROSCOPIC AND OPEN CHOLECYSTECTOMY (STUDY OF 50 ...
COMPARATIVE STUDY BETWEEN LAPAROSCOPIC AND OPEN CHOLECYSTECTOMY (STUDY OF 50 ...COMPARATIVE STUDY BETWEEN LAPAROSCOPIC AND OPEN CHOLECYSTECTOMY (STUDY OF 50 ...
COMPARATIVE STUDY BETWEEN LAPAROSCOPIC AND OPEN CHOLECYSTECTOMY (STUDY OF 50 ...KETAN VAGHOLKAR
 

What's hot (20)

In most cases evar substituted conventional repaire for ruptured aaa why
In most cases evar substituted conventional repaire for  ruptured aaa whyIn most cases evar substituted conventional repaire for  ruptured aaa why
In most cases evar substituted conventional repaire for ruptured aaa why
 
Staple line reinforcement
Staple line reinforcementStaple line reinforcement
Staple line reinforcement
 
COMPOSITE GRAFT: ANTROPYLORUS TRANSPOSITION AND GLUTEUS MAXIMUS WRAP
COMPOSITE GRAFT: ANTROPYLORUS TRANSPOSITION AND GLUTEUS MAXIMUS WRAPCOMPOSITE GRAFT: ANTROPYLORUS TRANSPOSITION AND GLUTEUS MAXIMUS WRAP
COMPOSITE GRAFT: ANTROPYLORUS TRANSPOSITION AND GLUTEUS MAXIMUS WRAP
 
Dr Pradeep Jain Fortis Hospital - Current Applications of Lap in GI Surgery
Dr Pradeep Jain Fortis Hospital - Current Applications of Lap in GI SurgeryDr Pradeep Jain Fortis Hospital - Current Applications of Lap in GI Surgery
Dr Pradeep Jain Fortis Hospital - Current Applications of Lap in GI Surgery
 
International Journal of Hepatology & Gastroenterology
International Journal of Hepatology & GastroenterologyInternational Journal of Hepatology & Gastroenterology
International Journal of Hepatology & Gastroenterology
 
Allograft replacement for infrarenal aortic graft infection
Allograft  replacement  for infrarenal  aortic graft infectionAllograft  replacement  for infrarenal  aortic graft infection
Allograft replacement for infrarenal aortic graft infection
 
New technology new technique radiofrequency results 5 years
New technology new technique  radiofrequency results 5 yearsNew technology new technique  radiofrequency results 5 years
New technology new technique radiofrequency results 5 years
 
Caustic esophageal stricture from diagnosis untill cure
Caustic esophageal stricture from diagnosis untill cureCaustic esophageal stricture from diagnosis untill cure
Caustic esophageal stricture from diagnosis untill cure
 
Resection of vena cava during major hepatectomies
Resection of vena cava during major hepatectomiesResection of vena cava during major hepatectomies
Resection of vena cava during major hepatectomies
 
Art 3 a10.1007-2fs00464-011-2009-2
Art 3 a10.1007-2fs00464-011-2009-2Art 3 a10.1007-2fs00464-011-2009-2
Art 3 a10.1007-2fs00464-011-2009-2
 
Robotic pancreatectomy. Pancreatectomia robótica.
Robotic pancreatectomy. Pancreatectomia robótica.Robotic pancreatectomy. Pancreatectomia robótica.
Robotic pancreatectomy. Pancreatectomia robótica.
 
Glissonian approach for laparoscopic liver resections
Glissonian approach for laparoscopic liver resectionsGlissonian approach for laparoscopic liver resections
Glissonian approach for laparoscopic liver resections
 
Laparoscopic Ivor Lewis Esophagectomy
Laparoscopic Ivor Lewis EsophagectomyLaparoscopic Ivor Lewis Esophagectomy
Laparoscopic Ivor Lewis Esophagectomy
 
Fulltext
FulltextFulltext
Fulltext
 
Hybrid tevar for the treatment of aortic dissection
Hybrid tevar for the treatment of aortic dissectionHybrid tevar for the treatment of aortic dissection
Hybrid tevar for the treatment of aortic dissection
 
Advanced and laparoscopic liver, bile duct and pancreatic surgery
Advanced and laparoscopic liver, bile duct and pancreatic surgeryAdvanced and laparoscopic liver, bile duct and pancreatic surgery
Advanced and laparoscopic liver, bile duct and pancreatic surgery
 
Massive bone allografts
Massive bone allograftsMassive bone allografts
Massive bone allografts
 
downloadfile-7
downloadfile-7downloadfile-7
downloadfile-7
 
En pratique : Hépatectomie majeure ou "economique" quand les deux sont possi...
En pratique : Hépatectomie majeure ou "economique" quand les deux sont possi...En pratique : Hépatectomie majeure ou "economique" quand les deux sont possi...
En pratique : Hépatectomie majeure ou "economique" quand les deux sont possi...
 
COMPARATIVE STUDY BETWEEN LAPAROSCOPIC AND OPEN CHOLECYSTECTOMY (STUDY OF 50 ...
COMPARATIVE STUDY BETWEEN LAPAROSCOPIC AND OPEN CHOLECYSTECTOMY (STUDY OF 50 ...COMPARATIVE STUDY BETWEEN LAPAROSCOPIC AND OPEN CHOLECYSTECTOMY (STUDY OF 50 ...
COMPARATIVE STUDY BETWEEN LAPAROSCOPIC AND OPEN CHOLECYSTECTOMY (STUDY OF 50 ...
 

Similar to Endoscopy in Gastrointestinal Oncology - Slide 13 - M. Traina - Post transplantation strictures: which stent type and optimal staging?

Prospective evaluation of single operator peroral cholangioscopy in liver
Prospective evaluation of single operator peroral cholangioscopy in liverProspective evaluation of single operator peroral cholangioscopy in liver
Prospective evaluation of single operator peroral cholangioscopy in liverDr. Zubin Sharma M.D.
 
Nss and mit final
Nss and mit finalNss and mit final
Nss and mit finalAhmed Eliwa
 
Surgical Treatment of Primary Malignant Tumours of the Distal Tibia.pptx
Surgical Treatment of Primary Malignant Tumours of the Distal Tibia.pptxSurgical Treatment of Primary Malignant Tumours of the Distal Tibia.pptx
Surgical Treatment of Primary Malignant Tumours of the Distal Tibia.pptxPunyaChopra1
 
Laparoscopic gastrectomies for cancer
Laparoscopic gastrectomies for cancerLaparoscopic gastrectomies for cancer
Laparoscopic gastrectomies for cancerEduardo Guzman
 
Standard versus tubeless mini percutaneous nephrolithotomy
Standard versus tubeless mini percutaneous nephrolithotomyStandard versus tubeless mini percutaneous nephrolithotomy
Standard versus tubeless mini percutaneous nephrolithotomyYouttam Laudari
 
Management of cervical esophageal anastomotic stricture
Management of cervical esophageal anastomotic strictureManagement of cervical esophageal anastomotic stricture
Management of cervical esophageal anastomotic stricturezeeshanrahman86
 
Endoscopic_Ultrasound_Guided_Biliary_Interventions.pptx
Endoscopic_Ultrasound_Guided_Biliary_Interventions.pptxEndoscopic_Ultrasound_Guided_Biliary_Interventions.pptx
Endoscopic_Ultrasound_Guided_Biliary_Interventions.pptxDrdeepak17
 
Laparoscopic Partial Nephrectomy of Hilar Tumors with Cold Ischemia
Laparoscopic Partial Nephrectomy of Hilar Tumors with Cold IschemiaLaparoscopic Partial Nephrectomy of Hilar Tumors with Cold Ischemia
Laparoscopic Partial Nephrectomy of Hilar Tumors with Cold Ischemiaguestd58ac53
 
Managemnt of pancreatic necrosis and fluid collection
Managemnt of pancreatic necrosis and fluid collectionManagemnt of pancreatic necrosis and fluid collection
Managemnt of pancreatic necrosis and fluid collectionAbhishek Yadav
 
Prospective evaluation of single operator peroral cholangioscopy in liver
Prospective evaluation of single operator peroral cholangioscopy in liverProspective evaluation of single operator peroral cholangioscopy in liver
Prospective evaluation of single operator peroral cholangioscopy in liverDr. Zubin Sharma M.D.
 
journal club IOC VS MRCP.pptx
journal club IOC VS MRCP.pptxjournal club IOC VS MRCP.pptx
journal club IOC VS MRCP.pptxUsmleGuy1
 
Iatrogenic biliary tract injuries
Iatrogenic biliary tract  injuries Iatrogenic biliary tract  injuries
Iatrogenic biliary tract injuries Omar Abu Safieh
 
Trans-anal Endoscopic Microsurgery TEM
Trans-anal Endoscopic Microsurgery TEMTrans-anal Endoscopic Microsurgery TEM
Trans-anal Endoscopic Microsurgery TEMkhaled Mestareehy
 
PCN ESWL.pptx
PCN ESWL.pptxPCN ESWL.pptx
PCN ESWL.pptxMahyar17
 

Similar to Endoscopy in Gastrointestinal Oncology - Slide 13 - M. Traina - Post transplantation strictures: which stent type and optimal staging? (20)

GIT J Club ercp mistakes UEG.
GIT J Club ercp mistakes UEG.GIT J Club ercp mistakes UEG.
GIT J Club ercp mistakes UEG.
 
Prospective evaluation of single operator peroral cholangioscopy in liver
Prospective evaluation of single operator peroral cholangioscopy in liverProspective evaluation of single operator peroral cholangioscopy in liver
Prospective evaluation of single operator peroral cholangioscopy in liver
 
Bile duct injury
Bile duct injuryBile duct injury
Bile duct injury
 
Nss and mit final
Nss and mit finalNss and mit final
Nss and mit final
 
Surgical Treatment of Primary Malignant Tumours of the Distal Tibia.pptx
Surgical Treatment of Primary Malignant Tumours of the Distal Tibia.pptxSurgical Treatment of Primary Malignant Tumours of the Distal Tibia.pptx
Surgical Treatment of Primary Malignant Tumours of the Distal Tibia.pptx
 
Laparoscopic gastrectomies for cancer
Laparoscopic gastrectomies for cancerLaparoscopic gastrectomies for cancer
Laparoscopic gastrectomies for cancer
 
2
22
2
 
Standard versus tubeless mini percutaneous nephrolithotomy
Standard versus tubeless mini percutaneous nephrolithotomyStandard versus tubeless mini percutaneous nephrolithotomy
Standard versus tubeless mini percutaneous nephrolithotomy
 
Management of cervical esophageal anastomotic stricture
Management of cervical esophageal anastomotic strictureManagement of cervical esophageal anastomotic stricture
Management of cervical esophageal anastomotic stricture
 
Endoscopic_Ultrasound_Guided_Biliary_Interventions.pptx
Endoscopic_Ultrasound_Guided_Biliary_Interventions.pptxEndoscopic_Ultrasound_Guided_Biliary_Interventions.pptx
Endoscopic_Ultrasound_Guided_Biliary_Interventions.pptx
 
Bile duct injury.pptx
Bile duct injury.pptxBile duct injury.pptx
Bile duct injury.pptx
 
Laparoscopic Partial Nephrectomy of Hilar Tumors with Cold Ischemia
Laparoscopic Partial Nephrectomy of Hilar Tumors with Cold IschemiaLaparoscopic Partial Nephrectomy of Hilar Tumors with Cold Ischemia
Laparoscopic Partial Nephrectomy of Hilar Tumors with Cold Ischemia
 
Managemnt of pancreatic necrosis and fluid collection
Managemnt of pancreatic necrosis and fluid collectionManagemnt of pancreatic necrosis and fluid collection
Managemnt of pancreatic necrosis and fluid collection
 
Role of surgery in metastatic colorectal cancer
Role of surgery in metastatic colorectal cancerRole of surgery in metastatic colorectal cancer
Role of surgery in metastatic colorectal cancer
 
Prospective evaluation of single operator peroral cholangioscopy in liver
Prospective evaluation of single operator peroral cholangioscopy in liverProspective evaluation of single operator peroral cholangioscopy in liver
Prospective evaluation of single operator peroral cholangioscopy in liver
 
journal club IOC VS MRCP.pptx
journal club IOC VS MRCP.pptxjournal club IOC VS MRCP.pptx
journal club IOC VS MRCP.pptx
 
Iatrogenic biliary tract injuries
Iatrogenic biliary tract  injuries Iatrogenic biliary tract  injuries
Iatrogenic biliary tract injuries
 
Trans-anal Endoscopic Microsurgery TEM
Trans-anal Endoscopic Microsurgery TEMTrans-anal Endoscopic Microsurgery TEM
Trans-anal Endoscopic Microsurgery TEM
 
Osteosarcoma ppt
Osteosarcoma pptOsteosarcoma ppt
Osteosarcoma ppt
 
PCN ESWL.pptx
PCN ESWL.pptxPCN ESWL.pptx
PCN ESWL.pptx
 

More from European School of Oncology

ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...European School of Oncology
 
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...European School of Oncology
 
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...European School of Oncology
 
A. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomasA. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomasEuropean School of Oncology
 
A. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomasA. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomasEuropean School of Oncology
 
S. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccineS. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccineEuropean School of Oncology
 
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...European School of Oncology
 
J.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the artJ.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the artEuropean School of Oncology
 
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...European School of Oncology
 
T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer European School of Oncology
 
N. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancerN. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancerEuropean School of Oncology
 
S. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the artS. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the artEuropean School of Oncology
 
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...European School of Oncology
 
G. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the artG. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the artEuropean School of Oncology
 
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...European School of Oncology
 

More from European School of Oncology (20)

ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
ABC1 - X. Zhang - Metastasis seed pre-selection driven by the microenvironmen...
 
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
G. Ceresoli - Prostate and renal cancer - State of the art and update on syst...
 
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
A. Shamseddine - Prostate and renal cancer - State of the art and update on s...
 
W. Hassen - Bladder cancer - Guidelines
W. Hassen - Bladder cancer - GuidelinesW. Hassen - Bladder cancer - Guidelines
W. Hassen - Bladder cancer - Guidelines
 
A. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomasA. Stathis - New drugs in the treatment of lymphomas
A. Stathis - New drugs in the treatment of lymphomas
 
H. Khaled - Bladder cancer - State of the art
H. Khaled - Bladder cancer - State of the artH. Khaled - Bladder cancer - State of the art
H. Khaled - Bladder cancer - State of the art
 
A. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomasA. Stathis - Lymphomas - New drugs in the treatment of lymphomas
A. Stathis - Lymphomas - New drugs in the treatment of lymphomas
 
1 azim
1 azim1 azim
1 azim
 
H. Azim - Lymphomas - State of the art
H. Azim - Lymphomas - State of the artH. Azim - Lymphomas - State of the art
H. Azim - Lymphomas - State of the art
 
S. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccineS. Khleif - Ovarian cancer - General lecture on vaccine
S. Khleif - Ovarian cancer - General lecture on vaccine
 
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
A. Hassan - Ovarian cancer - Guidelines and clinical case presentation (2-3 c...
 
J.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the artJ.B. Vermorken - Ovarian cancer - State of the art
J.B. Vermorken - Ovarian cancer - State of the art
 
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
A. Hassan - Cervical cancer - Guidelines and clinical case presentation (2-3 ...
 
V. Kesic - Cervical cancer - State of the art
V. Kesic - Cervical cancer - State of the art V. Kesic - Cervical cancer - State of the art
V. Kesic - Cervical cancer - State of the art
 
T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer T. Cufer - Breast cancer - State of the art for advanced breast cancer
T. Cufer - Breast cancer - State of the art for advanced breast cancer
 
N. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancerN. El Saghir - Breast cancer - State of the art for early breast cancer
N. El Saghir - Breast cancer - State of the art for early breast cancer
 
S. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the artS. Cascinu - Liver/Hepatobiliary - State of the art
S. Cascinu - Liver/Hepatobiliary - State of the art
 
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
S. Cascinu - Colorectal cancer - Guidelines and clinical case presentation (2...
 
G. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the artG. Pentheroudakis - Colorectal cancer - State of the art
G. Pentheroudakis - Colorectal cancer - State of the art
 
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
A. Tfayli - Head and neck - Guidelines and clinical case presentation (2-3 ca...
 

Endoscopy in Gastrointestinal Oncology - Slide 13 - M. Traina - Post transplantation strictures: which stent type and optimal staging?

  • 1. Post transplantation strictures: which stent type and optimal staging? Mario Traina 1
  • 2. Post transplantation strictures Background Biliary complications represent a serious source of morbidity after OLT (Orthotopic Liver Transplantation) and LRLT (Living Related Liver Transplantation) The rate of biliary complications in transplant recipients ranging from 8% to 35% in the published series The most common biliary complication is the anastomotic stricture, which is followed by biliary leakage, although patients often develop more than one complication 2
  • 3. Post transplantation strictures Predictors of biliary complications by multivariate analysis • Take-back surgery after liver transplantation was identified as strongly predictive of the development of a biliary problem. • Patients who received a DCD (Donation after Cardiac Death) graft had a 4.5-fold increased risk of the development of a biliary complication. • Patients with PSC (primary sclerosing clolangitis) had a 2.8-fold increase in the risk of the development of biliary problems. 3
  • 4. Post transplantation strictures Standard Treatment The standard endoscopic treatment consists in performing ERCP, with sphincterotomy plus stent placement for biliary leaks, or progressive pneumatic dilatation with stents placement for biliary stenosis alone Results : The endoscopic treatment of biliary complications reaches a success rate of about 70-80% after orthotopic liver transplantation and 60% after living-related liver transplantation. 4
  • 5. Post transplantation strictures Predictors of endoscopic treatment outcomes •Patients who had grafts from DCD and in whom biliary complications developed were less likely to respond to endoscopic therapy. •Patients who received a living donor liver transplant were less likely to respond to endoscopic therapy. •Finally, transplant recipients who had undergone take-back surgery for nonbiliary indications, particularly bleeding, had less favorable endoscopic results for the management of biliary problems. 5
  • 6. Multivariate analysis demostrated that treatment success was directly related to the number of stent used 6
  • 7. Post transplantation strictures Which stent type The rationale for using covered metallic stent was to improve the durability of patency, because the plastic stents have limited patency rate and become occluded within 3 to 6 months, so that frequent replacement and an increasing number of stents are required. 7
  • 8. Post transplantation strictures SEMS (self-expanding metal stents) • Uncovered • Partially covered • Fully covered: Silicon, Permalume®, PTFE (Polytetrafluoroethylene), Gore-tex, • Steel, Nitinol, Platinol™ • Conforming to anatomy Antimigration properties • Flared type • Anchoring fins • Anchoring flaps • Bumpy 8
  • 10. Post transplantation strictures Treatment with SEMS •Traina M, Tarantino I, Barresi L, et al. Efficacy and safety of fully covered selfexpandable metallic stents in biliary complications after liver transplantation: a preliminary study. Liver Transpl 2009; 15:1493–1498. •Tee HP, James MW, Kaffes AJ. Placement of removable metal biliary stent in postorthotopic liver transplantation anastomotic stricture. World J Gastroenterol 2010; 16:3597–3600. •Garcıa-Pajares F, Sanchez-Antolın G, Pelayo SL, et al. Covered metal stents for the treatment of biliary complications after orthotopic liver transplantation. Transplant Proc 2010; 42:2966–2969. •Chaput U, Scatton O, Bichard P, et al. Temporary placement of partially covered self-expandable metal stents for anastomotic biliary strictures after liver transplantation: a prospective, multicenter study. Gastrointest Endosc 2010; 72:1167–1174. 10
  • 16. Post transplantation strictures Now that fully CSEMS are available, partially CSEMS should not be used due to imbedding of the uncovered portion, which has the potential for causing stent-induced strictures and to make stent removal difficult or impossible. Todd H. Baron 16
  • 17. Post transplantation strictures • Our preliminary data showed that in patients who do not respond to standard endoscopic treatment, the placement of a fully covered metal stent could be considered a valid alternative to surgery. • These results were limited in generalizability by a short follow-up time (a mean of 10 months) and a small patient’s cohort. With the present study we aim to implement our previous experience with longer follow-up period and higher number of treated patients, analyzing the efficacy of SEMS both as first-line approach and in patients in whom plastic stents failed in resolving the biliary complication 17
  • 18. Post transplantation strictures AIMS of the study To evaluate the clinical success in a large cohort of patients treated with SEMS, after failure of conventional endoscopic treatment*, and with a long follow up. To evaluate the clinical success of SEMS placement as first procedure in a subgroup of consecutive treated patients. *Failure of endoscopic treatment was defined as: 1) evidence of continuous bile leakage despite endoscopic stent placement; 2) persistence of stenosis after one year despite multiple dilatation and stent placement 18
  • 19. Post transplantation strictures Study design • Prospective observational study Population of patients with biliary complications after liver transplantation (OLT and LRLT) After failure of conventional First diagnosis endoscopic treatment 19
  • 20. Post transplantation strictures Materials and Methods From January 2008 to August 2010, all failures of endoscopic conventional therapy, were treated with SEMS placement according with our previous series. From January to August 2010, we also tried to treat all new cases without any previous endoscopic treatments, with SEMS placement as first approach. 20
  • 21. Post transplantation strictures Results 54 consecutive patients were treated with SEMS for biliary stenosis and/or leak after liver transplantation and were included in the study 39 after failure of 15 conventional as first approach treatment 21
  • 22. Post transplantation strictures Patients Characteristic GROUP 1 (39) GROUP 2 (15) MALE/FEMALE N 25/14 10/5 MEAN AGE 60.1 ± 8.9 59.1 ± 6.6 LIVER DONORS •Cadaveric 33 (84.6%) 15 (100%) • Living 6 (15.4%) - BILIARY ANASTOMOSIS •Duct-to-duct 35 (89.7) 15 (100) •Multiple anastomosis 4 (10.3) - COMPLICATIONS • Stenosis 32 (82) 15 (100) • Stenosis plus leak 6 (15.4) - • Leak 1 (2.6) - 22
  • 23. Post transplantation strictures Results GROUP 1 (39) GROUP 2 (15) SOLUTION N (%) 28/39 (71.8) 8/15 (53.3) MEAN FOLLOW-UP 16.6±9 months 10.4±4.5 months RECURRENCE n (%) 4/28 (14.3) 2/8 (25) TIME OF RECURRENCE 8.5 months (3-24) 1 and 13 months SEMS MIGRATION n (%) 13/39 (33.3) 7/15 (46.7) 23
  • 24. Post transplantation strictures Anchoring Fins Removal may be problematic because of these multiple anchoring fins, which can cause ulceration and bleeding from the mucosa as the SEMS is extracted. 24
  • 29. Post transplantation strictures Conclusions • ERCP with conventional treatment is a safe first-line approach for post-OLT biliary complications. • In patients in whom the standard approach fails temporary SEMS placement is able to solve biliary complication and may eliminate the need for surgery in almost ¾ of cases. • SEMS placement is not useful and not recommended as first line approach soon after the diagnosis of biliary complications • Partially CSEMS should not be used due to imbedding of the uncovered portion • The ideal stent: fully covered, flared, conforming to anatomy, with a safe antimigration system 29